MediPharm Labs Corp
MLZ
Company Profile
Business description
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.
Contact
151 John Street
BarrieONL4N 2L1
CANT: +1 705 719-7425
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
166
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,149.80 | 8.90 | -0.11% |
| CAC 40 | 8,042.95 | 51.25 | -0.63% |
| DAX 40 | 22,891.68 | 107.47 | -0.47% |
| Dow JONES (US) | 41,985.35 | 32.03 | 0.08% |
| FTSE 100 | 8,646.79 | 55.20 | -0.63% |
| HKSE | 23,640.85 | 48.87 | -0.21% |
| NASDAQ | 17,784.05 | 92.42 | 0.52% |
| Nikkei 225 | 37,676.97 | 0.09 | -0.00% |
| NZX 50 Index | 12,126.65 | 13.11 | 0.11% |
| S&P 500 | 5,667.56 | 4.67 | 0.08% |
| S&P/ASX 200 | 7,926.50 | 4.70 | -0.06% |
| SSE Composite Index | 3,364.90 | 0.07 | 0.00% |